We found 116 results for Cancer and Blood Disorders.

People In Business

People In Business People In Business WINSTON-SALEM, N.C. - Kevin H. Peacock, M.D. has joined Wake Forest University Baptist Medical Center as an assistant professor of Internal Medicine - Hematology and Oncology, specializing in evaluation and treatment of cancer and blood disorders. He will provide

Read More

Study Finds that Blood Test Can Gauge Prostate Cancer Risk

New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. Researchers at Wake Forest University School of Medicine and colleagues found that five genetic variants previously associated with prostate cancer risk have a strong cumulative effect.

Read More

Cancer Researchers at Wake Forest Baptist Receive $9 Million Grant to Study Aggressive Brain Cancer

Glioblastoma is the most aggressivecancerthat originates in thebrain. Current therapies can slow the disease, but more often than not can’t cure it.

Read More

Too Much Calcium in Blood May Increase Risk of Fatal Prostate Cancer

Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University School of Medicine and the University of Wisconsin.

Read More

Blood Pressure Drug Shows Potential as Lung Cancer Treatment

A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine. Reporting in the journal Cancer Research, the scientists said that in mice treated with the hormone, angiotensin-(1-7), tumor volume decreased by 30 percent. In mice that did not receive the treatment, the tumor size more than doubled. Patricia E. Gallagher, Ph.D., and E. Ann Tallant, Ph.D., senior researchers on the project, had previously reported a similar effect in lung cancer cells studied in the laboratory.

Read More

Cancer Drug May Reduce Kidney Disease in Lupus

Cancer Drug May Reduce Kidney Disease in Lupus Cancer Drug May Reduce Kidney Disease in Lupus WINSTON-SALEM, N.C. - A drug that is already being tested as an anticancer agent, especially in lymphoma, may also reduce the kidney disease that is a result of systemic lupus, according to a researcher at Wake

Read More

Blood Pressure Hormone May Inhibit Growth of Lung Cancer

Blood Pressure Hormone May Inhibit Growth of Lung Cancer Blood Pressure Hormone May Inhibit Growth of Lung Cancer WINSTON-SALEM, N.C.- A hormone that is important in the control of blood pressure may also inhibit the growth of lung cancer cells, say scientists at Wake Forest University Baptist Medical Center,

Read More

$250,000 Komen Foundation Grant Awarded to Wake Forest University Scientists

$250,000 Komen Foundation Grant Awarded to Wake Forest University Scientists $250,000 Komen Foundation Grant Awarded to Wake Forest University Scientists WINSTON-SALEM, N.C. - The Susan G. Komen Breast Cancer Foundation has awarded a $250,000 grant to two researchers in the Hypertension and Vascular Disease C

Read More

Suppressing Growth Hormone in Early Adulthood May Prevent Cancer

Suppressing Growth Hormone in Early Adulthood May Prevent Cancer Suppressing Growth Hormone in Early Adulthood May Prevent Cancer WINSTON-SALEM, N.C. - A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer,

Read More

Study Finds Gene Linked to Aggressive Prostate Cancer

Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive prostate cancer. Research teams from the Translational Genomics Research Institute (TGen), Wake Forest University School of Medicine, the Karolinska Institute in Stockholm, Sweden, and Johns Hopkins Medical Institutions made the discovery jointly.

Read More